Meridien Research is a clinical research site located in Orlando, Florida, United States 32801.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
Meridien Research has participated in 2 clinical trials.
Therapeutic areas: Bipolar I Disorder, Manic Episode, Schizophrenia.
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Boehringer Ingelheim.
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Meridien Research has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Meridien Research has 2 clinical trials on record. Their work covers Bipolar I Disorder, Manic Episode, Schizophrenia.
Meridien Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.